Breast imaging centers run on volume, and the Siemens Mammomat Revelation is built to move patients through screening efficiently while capturing the tomosynthesis data that dense breast tissue demands. Practices that replace a 2D-only mammography unit with a system like the Revelation typically see their callback rate drop and their radiologist confidence on dense cases improve. The capital question is how to structure the purchase so the monthly cost fits inside the revenue the room generates.
The Mammomat Revelation is Siemens Healthineers' full-field digital mammography platform with integrated tomosynthesis. It uses Siemens' PRIME technology to reconstruct 3D slice images from the same low-dose acquisition pass that produces the 2D synthetic mammogram, so there is no second exposure for the patient. The detector covers the full breast field, and the system supports both screening and diagnostic workflows from the same gantry. Financing one is our work, and we handle these purchases regularly enough to know what lenders want to see from breast imaging facilities of every size.
What the Mammomat Revelation Costs and How Terms Work
New Mammomat Revelation systems with full tomosynthesis capability carry list prices running about $300k to $500k depending on configuration, software options, and whether the facility needs associated room upgrades or a new compression paddle set. Certified pre-owned units are available through Siemens Healthineers' own refurbishment program and through independent biomedical dealers, and those can come in meaningfully lower.
We finance mammography equipment starting at $50,000, and most Revelation purchases land well above that floor. Terms of 60 to 84 months are standard for a system in this price range. Longer terms lower your monthly obligation and preserve cash flow for staffing and consumables, but you pay more in total finance charges over the life of the deal. Shorter terms cost less overall and build equity faster, which matters if you plan to use a sale-leaseback later to pull capital out of a paid-down asset.
A fair market value lease makes sense for facilities that expect to upgrade when the next generation of tomosynthesis arrives and want the option to return or refi at term end rather than own an aging system. A dollar-buyout lease or term loan is better when the practice intends to keep the unit long-term or when Section 179 expensing in the year of purchase is a priority. Our fair market value lease and dollar-buyout lease pages walk through the structural differences in plain terms.
Clinical and Workflow Features Worth Understanding Before You Finance
The Mammomat Revelation's PRIME tomosynthesis acquisition produces a complete 3D slice dataset plus a synthetic 2D image from a single low-dose sweep. Radiologists reading on the Revelation do not need the full 2D acquisition to complete their reads, which reduces patient dose compared to systems that require separate 2D and 3D exposures. The system's Automatic Exposure Control (AEC) and tube motion technology keep the acquisition arc smooth and the geometry consistent across body habitus ranges.
Patient positioning is assisted by the system's motorized bucky arm and a range of compression paddles covering standard, contact, and spot compression modes. The paddle pressure readout and compression force feedback help technologists achieve consistent positioning across high-volume screening days. Integration with Siemens' syngo.Breast Care software and standard DICOM connections to most PACS platforms is straightforward.
Facilities adding the Revelation to a breast health program that already includes stereotactic breast biopsy capability should consider whether the biopsy system is compatible with the Revelation detector. Siemens offers add-on biopsy guidance options that integrate with the Mammomat line, and bundling the primary system with biopsy capability in the same financing transaction can simplify the overall project cost.
Facilities That Typically Finance a Mammomat Revelation
Dedicated breast health centers replacing an older 2D digital mammography unit are the most common buyers. The move from 2D to tomosynthesis is now well established in breast screening guidelines, and facilities that have not yet made the transition face competitive pressure from programs that already offer 3D screening.
Women's health and OB/GYN clinics that offer in-house mammography rather than referring to a separate imaging center benefit from the Revelation's ability to handle both screening and diagnostic workup from the same platform. Hospitals adding a second mammography suite to reduce wait times and outpatient imaging centers expanding their breast program both fit well. Mobile mammography providers looking for a high-quality unit for a dedicated trailer should also review our mobile imaging trailer financing options alongside the equipment itself.
A comparable breast imaging option worth evaluating alongside the Mammomat Revelation is the Fujifilm ASPIRE Cristalle mammography system, which also offers tomosynthesis and is frequently available through independent dealers.
What We Need to Move Your Application Forward
Applications up to roughly $400,000 can typically be processed without full financial statements. For those transactions, we need a completed credit application and three months of business bank statements showing consistent operating activity. Decisions for application-only transactions typically come back within two to three business days.
Larger transactions or practices with prior credit issues require additional documentation: most recent two years of business tax returns, a current interim profit and loss statement, and personal financial statements from any owner with 20 percent or more equity. We work with B and C credit profiles. A recent tax lien, a prior bankruptcy, or a thin credit file does not automatically close the door, but it does affect which lenders we match you with and how the structure looks.
New breast imaging practices with limited operating history have access to our new practice startup financing programs, which use personal credit strength and projected revenue to underwrite the loan where business history is thin.
Start Your Mammomat Revelation Financing Application
Breast imaging equipment moves quickly in the secondary market. When you find the Revelation configuration you want, submit an application so we can have a decision ready before the unit is gone. We work with new breast centers and established programs alike, and our process moves from application to funded deal in about one to two weeks.
Related Financing Paths
Questions about Siemens Mammomat Revelation Mammography Financing
Clear answers on equipment eligibility, documentation, timing, and the financing path before you send the full file.
Can I finance a Mammomat Revelation that is still on order from Siemens with a delivery date several months out?
Yes. We can issue an approval and hold the commitment while the unit is in production. Funding releases on delivery and acceptance, not at application. There is no cost to hold an approval, and we confirm the commitment remains valid through the delivery window.
Does my practice need to be Mammography Quality Standards Act (MQSA) certified before we can get financing?
You do not need existing MQSA certification to apply for financing, but the lender will want to see a realistic path to certification before funding. New breast programs typically demonstrate this through a letter from an accreditation body confirming application, or through documentation that a certified lead interpreting physician is on staff or contracted.
We already own an older Siemens mammography unit with equity in it. Can we use that to reduce what we finance on the Revelation?
A trade-in arrangement through the dealer is the most direct route, but we can also structure a sale-leaseback on your existing unit to generate cash that goes toward the new system's down payment. Both options are worth modeling. The sale-leaseback route keeps the equipment in your facility while you transition rather than requiring the dealer to remove it mid-workflow.
Is deferred payment financing available for a Revelation purchase?
Yes. Some lenders offer a 90-day payment deferral on qualified transactions, which can be useful if you are in the middle of a room buildout and the system will not be earning revenue for a few months after delivery. Deferred payment financing typically adds a small amount to the total finance cost but protects cash flow during the ramp period.
Bring this system into your room.
Send the Siemens Mammomat Revelation Mammography Financing quote, seller details, requested amount, and installation target. The imaging finance desk will map the next practical step.